About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

The Latest on the Expanded Access Trial for Abiraterone- New Locations

ABIRATERONE EXPANDED ACCESS Trial Site Contact Info – 3/25/11 for men with advanced prostate cancer (800) 457-6399 M-F, 9am –5pm, EST TRIAL link: http://www.clinicaltrials.gov/ct2/show/NCT01217697?term=abiraterone&recr=Open&rank=6 Basic Criteria: 1. testosterone less than 50 2. metastatic prostate cancer 3. no brain metastasis 4. failed chemo 5. no more than 2 different types of previous chemo […]

Bristol-Myers Squibb Wins U.S. Approval for Ipilimumab to Treat Melanoma – Good News for Men with Advanced Prostate Cancer

Bristol-Myers Squibb Co. announced today (March 25) that it has received FDA approval for ipilimumab, the first drug in a new family of medicines to treat advanced melanoma, the most deadly form of skin cancer. This is potentially good news for those of us who are fighting advanced prostate cancer as there is currently an [...]

FDA Perspective on Developing Novel Combination Therapies – What We Need

Increasingly it has become obvious to me and to many other individuals that our current drug approval and development process has a basic flaw. If you go to research conferences you quickly learn that there is probably no magic bullet to stop any type of cancer, including advanced prostate cancer. Current drug development focuses on [...]

Study Results Provide Evidence for First-Line Use of Firmagon (degarelix) in Advanced Prostate Cancer

Firmagon, the newly FDA approved gonadotropin-releasing hormone (GnRH) receptor blocker should perhaps be considered as a better alternative to the traditionally used ADT drugs like lupron and zoladex (GnRH agonists) which are the current standard of care. Recent data released from the ongoing five-year Firmagon (degarelix) extension study (CS21a) has demonstrated the long term efficacy [...]

Zoledronic Acid Also Induces Cell Death in Human Prostate Cancer Cells

Bisphosphonates, specifically Zometa, is commonly used in the treatment of men with advanced prostate cancer. Zometa is used to treat and protect bones from developing fractures. Bisphosphonates are potent inhibitors of bone resorption. Additionally, in vitro studies show that zolendronic acid also inhibits prostate cancer cell growth by activating apoptosis (A form of cell death [...]

YOU CAN WIN

For some reason Charlie Sheen thinks he is winning. It's one of his catch phrases after all. Sure he's rich and famous but he's also fired, and kind of a jerk. Sadly he's in denial about his seriously deep issues. In my book he's losing. He's losing big. He's a dad and he needs to [...]

By |2020-02-04T10:47:46-05:00March 22nd, 2011|LIFE, UNSOLICITED ADVICE & SUPPORT|3 Comments

More Good Data Supporting the Approval of Abiraterone

As we all anxiously wait for the FDA to finally make a determination about the pending application for approval of the investigational androgen biosynthesis inhibitor abiraterone acetate more data rolls in showing that supports the need to have a speedy approval. A new study published March 1, 2011, out of Italy adds support to the [...]

Fighting Cancer Is a Defense Department Obligation

Posted: March 18, 2011 10:24 AM : The Huffington Post "At last week's Innovative Minds in Prostate Cancer meeting, the speakers included not only doctors, but patients. We patients also help review the grant applications of the scientists. We seek innovative proposals to cure or slow prostate cancer, or reduce its notorious pain, and the [...]

Go to Top